CA153 - Overview: Cancer Antigen 15-3 (CA 15-3), Serum

Managing breast cancer patients when used in conjunction with clinical information and other diagnostic procedures Serial testing to assist in early detection of disease recurrence in previously treated stage II and III breast cancer...

F_2 - Overview: Coagulation Factor II Activity Assay, Plasma

Diagnosing a congenital deficiency (rare) of coagulation factor II Evaluating acquired deficiencies associated with liver disease or vitamin K deficiency, oral anticoagulant therapy, and antibody-induced deficiencies (eg, in association...

COM - Overview: Complement, Total, Serum

Detection of individuals with an ongoing immune process First-tier screening test for congenital complement deficiencies

CD14I - Overview: CD14 Immunostain, Technical Component Only

Marker of histiocytic and monocytic lineage and follicular dendritic cells

CIFA - Overview: Cutaneous Immunofluorescence Antibodies, IgA, Serum

Confirming the presence of IgA antibodies to diagnose pemphigoid, pemphigus, epidermolysis bullosa acquisita, or bullous lupus erythematosus

CD19I - Overview: CD19 Immunostain, Technical Component Only

Identification of normal and neoplastic B cells

CD10 - Overview: CD10 Immunostain, Technical Component Only

Phenotyping leukemias and lymphomas

CD13 - Overview: CD13 Immunostain, Technical Component Only

Marker of myeloid lineage

HSCRP - Overview: C-Reactive Protein, High Sensitivity, Serum

Assessment of risk of developing myocardial infarction in patients presenting with acute coronary syndromes Assessment of risk of developing cardiovascular disease or ischemic events in individuals who do not manifest disease at present

DEXT - Overview: Dermatopathology Consultation, Wet Tissue

Histologic diagnosis and differential diagnosis of cutaneous diseases